Response to Letter: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?

Affiliations

¹ Endocrinology Service, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-902, Brazil.
² Department of Endocrinology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.

Comment

Denise P Momesso et al. J Clin Endocrinol Metab. 2017.

. 2017 Jun 1;102(6):2115-2116.

doi: 10.1210/jc.2017-00110.

¹ Endocrinology Service, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-902, Brazil.
² Department of Endocrinology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.

No abstract available

Comment on

Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.
Momesso DP, Vaisman F, Yang SP, Bulzico DA, Corbo R, Vaisman M, Tuttle RM. Momesso DP, et al. J Clin Endocrinol Metab. 2016 Jul;101(7):2692-700. doi: 10.1210/jc.2015-4290. Epub 2016 Mar 29. J Clin Endocrinol Metab. 2016. PMID: 27023446 Free PMC article.
Letter to the Editor: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?
Giovanella L, Cosma C, Plebani M. Giovanella L, et al. J Clin Endocrinol Metab. 2017 Jun 1;102(6):2113-2114. doi: 10.1210/jc.2016-3983. J Clin Endocrinol Metab. 2017. PMID: 28586450 No abstract available.